StockData
Viridian Therapeutics, Inc.DE logo

Viridian Therapeutics, Inc.DE (VRDN) stock

VRDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30260% above fair value
$29.96−1.48 (-4.71%)

Close on Nov 20, 2026Market cap $3.39BP/E –Yield –

Viridian Therapeutics, Inc.DE total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Viridian Therapeutics, Inc.DE's total debt was $20.89M at Sep 30, 2025. For fiscal 2024 it was $20.58M, up 1.9% from the year before. The highest annual figure on record is $20.58M in fiscal 2024.

Annual total debt

PeriodPeriod endValueChange
FY2024Dec 31, 2024$20.58M+1.9%
FY2023Dec 31, 2023$20.21M–
FY2020Dec 31, 2020$0-100.0%
FY2019Dec 31, 2019$4.33M-45.9%
FY2018Dec 31, 2018$8.00M-19.3%
FY2017Dec 31, 2017$9.92M+251.8%
FY2016Dec 31, 2016$2.82M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025$20.89M+1.8%
Q2 FY2025Jun 30, 2025$20.79M+1.6%
Q1 FY2025Mar 31, 2025$20.69M+2.4%
Q4 FY2024Dec 31, 2024$20.58M–
Q3 FY2024Sep 30, 2024$20.52M+397.3%
Q2 FY2024Jun 30, 2024$20.45M+280.1%
Q4 FY2023Dec 31, 2023$20.21M+496.2%
Q4 FY2020Dec 31, 2020$0-100.0%
Q3 FY2020Sep 30, 2020$4.13M-21.5%
Q2 FY2020Jun 30, 2020$5.38M-13.0%
Q1 FY2020Mar 31, 2020$3.39M-52.2%
Q4 FY2019Dec 31, 2019$4.33M-45.9%
Q3 FY2019Sep 30, 2019$5.26M-41.0%
Q2 FY2019Jun 30, 2019$6.18M-37.1%
Q1 FY2019Mar 31, 2019$7.09M-29.2%
Q4 FY2018Dec 31, 2018$8.00M-19.3%
Q3 FY2018Sep 30, 2018$8.91M+540.8%
Q2 FY2018Jun 30, 2018$9.82M+425.0%
Q1 FY2018Mar 31, 2018$10.02M+326.8%
Q4 FY2017Dec 31, 2017$9.92M+251.8%
Q3 FY2017Sep 30, 2017$1.39M–
Q2 FY2017Jun 30, 2017$1.87M–
Q1 FY2017Mar 31, 2017$2.35M–
Q4 FY2016Dec 31, 2016$2.82M–

More Viridian Therapeutics, Inc.DE figures

See a number that looks wrong?